Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Operating Leases (2021 - 2025)

Beauty Health (SKIN) has disclosed Operating Leases for 5 consecutive years, with $10.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 12.75% to $10.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $10.6 million, a 12.75% decrease, with the full-year FY2024 number at $10.8 million, down 22.3% from a year prior.
  • Operating Leases was $10.6 million for Q3 2025 at Beauty Health, up from $8.5 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $13.9 million in Q4 2023 to a low of $8.5 million in Q2 2025.
  • A 5-year average of $11.7 million and a median of $12.1 million in 2022 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: increased 19.67% in 2024, then crashed 33.33% in 2025.
  • Beauty Health's Operating Leases stood at $12.8 million in 2021, then fell by 0.72% to $12.7 million in 2022, then rose by 9.68% to $13.9 million in 2023, then fell by 22.3% to $10.8 million in 2024, then decreased by 2.42% to $10.6 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Operating Leases are $10.6 million (Q3 2025), $8.5 million (Q2 2025), and $9.6 million (Q1 2025).